MTOR and breast carcinoma: Breast cancer with 8p11.23 inhibition of the amplified EIF4EBP1 may increase the dependency of the cancer cells to the activity of mTOR in order to secure active protein production, and thus may make these cells sensitive to inhibition of mTOR by drugs such as everolimus.